Zita Mendes, an accomplished inventor based in Lisbon, Portugal, has made significant strides in the field of pharmaceuticals. With a remarkable portfolio of 11 patents, Mendes has dedicated her career to developing innovative solutions for respiratory conditions and advancing pharmaceutical science.

Latest Patents

Among her recent patented inventions is a groundbreaking formulation of crystalline pharmaceutical co-crystals of glycopyrronium bromide with lactose. This invention presents a stoichiometric ratio of glycopyrronium bromide to lactose ranging from 1:2 to 2:1, characterized by X-ray diffraction (XRD) and differential scanning calorimetry (DSC). These co-crystals serve as an effective medicament for treating various respiratory issues, including chronic obstructive pulmonary disease (COPD), bronchitis, and asthma. Additionally, Mendes has developed a unique preparation process for aclidinium bromide, using specific solvents for optimal results. The resultant crystalline aclidinium bromide is defined by its distinct powder XRPD pattern and has applications in pharmaceutical compositions.

Career Highlights

Zita Mendes has a notable career, having worked with renowned companies such as Hovione Scientia Limited and Hovione Inter Limited. Her work in these organizations has contributed immensely to her expertise in drug formulation and pharmaceutical innovations, establishing her as a valuable contributor in her field.

Collaborations

Throughout her career, Mendes has collaborated with respected colleagues, including William Heggie and Susana Marto. These partnerships have fostered a dynamic exchange of ideas and expertise, further enhancing the collaborative nature of innovative research and development in her line of work.

Conclusion

Zita Mendes exemplifies the spirit of innovation through her dedicated work in pharmaceutical development. Her significant contributions, particularly in the realm of respiratory medication, underscore the importance of ongoing research and patent development in improving patient outcomes and advancing medical science.

This text is generated by artificial intelligence and may not be accurate.